| RS2524179405 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524179657 |
NFIA
|
Health Risk |
Pathogenic |
— |
| RS2524179769 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524179770 |
NFIA
|
Health Risk |
Pathogenic |
— |
| RS2524179794 |
NFIA
|
Health Risk |
Pathogenic |
Brain malformations with or without urinary tract defects, Brain malformations with or without urinary tract defects |
| RS2524179813 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524179835 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524181970 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524189017 |
DMD
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS2524189062 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524193671 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2524195963 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524195981 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524196706 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524196795 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524196968 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524196982 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524197153 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524198581 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2524199429 |
NFIA
|
Health Risk |
Pathogenic |
— |
| RS2524199730 |
VPS13D
|
Health Risk |
Pathogenic |
— |
| RS2524200215 |
NFIA
|
Health Risk |
Pathogenic |
— |
| RS2524200686 |
NFIA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2524200716 |
NFIA
|
Health Risk |
Pathogenic |
— |
| RS2524200871 |
NFIA
|
Health Risk |
Likely pathogenic |
Brain malformations with or without urinary tract defects, Brain malformations with or without urinary tract defects |
| RS2524201051 |
NFIA
|
Health Risk |
Likely pathogenic |
— |
| RS2524201617 |
DYM
|
Health Risk |
Likely pathogenic |
Dyggve-Melchior-Clausen syndrome, Dyggve-Melchior-Clausen syndrome |
| RS2524203249 |
ATP13A2
|
Health Risk |
Pathogenic |
Autosomal recessive spastic paraplegia type 78, Kufor-Rakeb syndrome |
| RS2524204010 |
ATAD3A
|
Health Risk |
Conflicting classifications of pathogenicity |
ATAD3A-related condition, ATAD3A-related condition |
| RS2524204781 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524205825 |
ARHGAP29
|
Health Risk |
Likely pathogenic |
ARHGAP29-related disorder, ARHGAP29-related disorder |
| RS2524206318 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2524206768 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2524207205 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2524207795 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524209758 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524209858 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524212771 |
ATAD3A
|
Health Risk |
Likely pathogenic |
Harel-Yoon syndrome, Harel-Yoon syndrome |
| RS2524214246 |
PAK3
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 30 |
| RS2524215565 |
RAB39B
|
Health Risk |
Pathogenic |
— |
| RS2524216149 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2524216359 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2524216449 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, Thyroid cancer |
| RS2524216621 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2524216795 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524216875 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2524217135 |
DBT
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 2 |
| RS2524219849 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524220280 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2524220978 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524222177 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2524225282 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524225532 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524225680 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524226891 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2524227371 |
GLMN
|
Health Risk |
Pathogenic |
— |
| RS2524233174 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2524234008 |
COL4A5
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS2524234146 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524234179 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524234474 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2524234713 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524234935 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524235865 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524235917 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524235953 |
COL4A5
|
Health Risk |
Likely pathogenic |
COL4A5-related disorder, X-linked Alport syndrome |
| RS2524235970 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524236030 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524236343 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524236373 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524243178 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524243548 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2524243658 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2524243984 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524244122 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524244170 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524244259 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524244745 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2524245019 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524245254 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524245423 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524245428 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524245571 |
DMD
|
Health Risk |
Pathogenic |
DMD-related disorder, DMD-related disorder |
| RS2524245595 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524245625 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524246510 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524247635 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2524250418 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2524254464 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524254479 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524254589 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524254615 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524254673 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524254870 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524255372 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2524255388 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2524255933 |
COL11A1
|
Health Risk |
Likely pathogenic |
COL11A1-related disorder, COL11A1-related disorder |
| RS2524258876 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524259917 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524260004 |
COL4A5
|
Health Risk |
Pathogenic |
— |